s.vanhecke
TL2 Moderator · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 27 May 2025 · last posted 2d
92 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #87 · Start Here › Welcome · 26 Jul 2026 · 0 likes On post #83 — agreed on the reasoning, with one qualification. Welcome. The orientation materials are pinned at the top of this category and they take about an hour.…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #131 · Evidence › Journal club · 25 Jul 2026 · 8 likes On post #127 — agreed on the reasoning, with one qualification. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #22 · Clinical › Comorbidities · 22 Jul 2026 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not…
-
Reading a home test result without over-claiming Replied, post #130 · Analytics › Home & field testing · 22 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #59 · Clinical › Prescriber conversations · 21 Jul 2026 · 2 likes post #58 answers the question as asked. The question underneath it is different. Asking about monitoring: understand what lab work will be done, how often, and what you…
-
Shakes versus food: a pragmatic assessment Replied, post #25 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 2 likes Worth separating two things that post #21 runs together. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than…
-
Tracking a shortage from primary sources rather than rumour Replied, post #109 · Access › Shortages · 18 Jul 2026 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Transit times by route, from a logged dataset Replied, post #13 · Sourcing › Logistics · 16 Jul 2026 · 11 likes This follows post #10 rather than contradicting it. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update…
-
What a certificate commits its issuer to — one year on Replied, post #101 · Analytics › COA interpretation · 3 Jul 2026 · 29 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Follow-up: Reading an interaction checker output critically Replied, post #28 · Practice › Interactions · 2 Jul 2026 · 0 likes post #27 answers the question as asked. The question underneath it is different. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and…
-
An appeal that succeeded, with the letter structure Replied, post #8 · Access › Insurance & coverage · 11 Jun 2026 · 5 likes On post #4 — agreed on the reasoning, with one qualification. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
Micronutrient adequacy at low total intake Replied, post #60 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 9 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Revisiting: What pooling buys you and what it destroys Replied, post #40 · Evidence › Meta-analyses · 1 Jun 2026 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Prescription portability between countries Replied, post #45 · Access › International · 27 May 2026 · 25 likes On post #41 — agreed on the reasoning, with one qualification. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #64 · Practice › Administration · 25 May 2026 · 0 likes I read post #62 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #122 · Practice › Storage & stability · 25 May 2026 · 2 likes On post #118 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Forced degradation studies: designing one that is informative Replied, post #61 · Analytics › Method validation · 23 May 2026 · 0 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
MS/MS sequence confirmation: what it costs and when it is worth it Started this topic · Analytics › Mass spectrometry · 20 May 2026 · 24 likes MS/MS sequence confirmation: what it costs and when it is worth it — setting out what I have, and where I think it stops being reliable. I would like to understand what…
-
Reading a trial's population section before its results Replied, post #33 · Evidence › Trials · 19 May 2026 · 3 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #33 · Practice › Storage & stability · 19 May 2026 · 4 likes Coming back to post #31, because the follow-up matters more than the original answer. Dating prepared solutions: write the date reconstitution on the vial in permanent…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #13 · Compounds › Oral incretins · 19 May 2026 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #16 · Compounds › Semaglutide · 4 May 2026 · 3 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #103 · Practice › Dosing & titration · 3 May 2026 · 12 likes post #102 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #11 · Analytics › COA interpretation · 29 Apr 2026 · 9 likes post #10 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #20 · Analytics › Mass spectrometry · 22 Apr 2026 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #48 · Evidence › Trials · 17 Apr 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
List price versus negotiated price versus what you pay Replied, post #46 · Access › Pricing · 12 Apr 2026 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. International pricing: the same compound costs very different amounts in different…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #3 · Pharmacology › Receptor biology · 9 Apr 2026 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #17 · Devices › Syringes & needles · 8 Apr 2026 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #123 · Access › Pricing · 22 Mar 2026 · 9 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #13 · Clinical › Bloodwork · 19 Mar 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #64 · Compounds › Repair & healing peptides · 14 Mar 2026 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Personal import allowances, compared — a second dataset Replied, post #81 · Access › International · 8 Mar 2026 · 0 likes On post #77 — agreed on the reasoning, with one qualification. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin…
-
Contributing data without breaching anyone's privacy Replied, post #58 · Data & Tools › Datasets · 6 Mar 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #14 · Compounds › Tirzepatide · 12 Feb 2026 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Storage and stability: published data on licensed tirzepatide formulations exists…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #30 · Practice › Reconstitution · 10 Feb 2026 · 0 likes Picking up post #27: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #16 · Analytics › Mass spectrometry · 23 Jan 2026 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #73 · Wellbeing › Mental health · 6 Jan 2026 · 28 likes post #72 is right about the mechanism and I think understates the practical bit. Identity and self-image: for some people, weight and body size are central to identity.…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #40 · Access › International · 4 Jan 2026 · 0 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Aggregates and why a purity assay may miss them entirely Replied, post #47 · Analytics › Impurities & related substances · 3 Jan 2026 · 0 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #30 · Regional › UK & Ireland · 2 Jan 2026 · 15 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #34 · Analytics › Method validation · 19 Dec 2025 · 3 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
The decimal-point error, and the habit that catches it Replied, post #87 · Practice › Reconstitution · 17 Dec 2025 · 20 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Filter needles: when they help and what they cost you Replied, post #6 · Devices › Syringes & needles · 16 Dec 2025 · 1 like I read post #4 twice before replying, because I had assumed the opposite. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard),…
-
Prescription requirements and telehealth models Replied, post #53 · Sourcing › Regulatory · 7 Dec 2025 · 29 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #21 · Practice › Storage & stability · 10 Nov 2025 · 10 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Tracking that stops updating and then resumes Replied, post #39 · Sourcing › Logistics · 25 Oct 2025 · 1 like Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #118 · Start Here › Welcome · 23 Oct 2025 · 10 likes Picking up post #115: that is the part I would want checked first. The compound and evidence pages are updated regularly and they are worth reading when you are new.…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #11 · Evidence › Journal club · 14 Sep 2025 · 28 likes Worth separating two things that post #7 runs together. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Adolescents: a distinct evidence base — one year on Replied, post #16 · Clinical › Special populations · 13 Sep 2025 · 2 likes Picking up post #13: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: Why appetite effects are mostly central Replied, post #37 · Pharmacology › Receptor biology · 10 Sep 2025 · 1 like On post #33 — agreed on the reasoning, with one qualification. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors.…
-
Reading a combination trial: attributing effect to components Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 19 Aug 2025 · 4 likes Worth separating two things that post #3 runs together. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #119 · Compounds › Semaglutide · 14 Aug 2025 · 26 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Journal club: the retatrutide phase 2 obesity paper Replied, post #5 · Evidence › Journal club · 7 Aug 2025 · 7 likes I read post #3 twice before replying, because I had assumed the opposite. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first…
-
How to ask about something you suspect is a bad idea Started this topic · Start Here › How to Ask · 3 Aug 2025 · 21 likes The question in the title: How to ask about something you suspect is a bad idea I will give what I have already checked below so nobody repeats it. Question in the…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #6 · Sourcing › Red flags · 22 Jul 2025 · 9 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #18 · Compounds › Retatrutide · 21 Jul 2025 · 26 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #61 · Compounds › Oral incretins · 9 Jul 2025 · 10 likes post #60 is right about the mechanism and I think understates the practical bit. Why an oral formulation is a formulation achievement: the molecule is the same but the…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 6 Jul 2025 · 19 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #11 · Compounds › Oral incretins · 21 Jun 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Needle changes between doses on a reusable pen Replied, post #14 · Devices › Pens & autoinjectors · 13 Jun 2025 · 0 likes post #13 is right about the mechanism and I think understates the practical bit. Dose counters: pens show the remaining number of doses. When the counter reaches zero,…
-
Pre-registering a personal experiment, seriously Replied, post #36 · Research Methods › N-of-1 designs · 28 May 2025 · 28 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Asking about a compound your prescriber has not heard of Replied, post #49 · Clinical › Prescriber conversations · 26 May 2025 · 0 likes Coming back to post #47, because the follow-up matters more than the original answer. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #115 · Practice › Reconstitution · 24 May 2025 · 11 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #7 · Data & Tools › Calculators · 20 May 2025 · 3 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Units, standards, and other things that quietly hold the world together Replied, post #36 · Lounge › Off topic · 4 May 2025 · 0 likes On post #32 — agreed on the reasoning, with one qualification. Community norms: if you want to discuss how the community should work (not moderation decisions, which go…
-
Metformin co-administration and additive GI effects Replied, post #32 · Practice › Interactions · 4 May 2025 · 26 likes Coming back to post #30, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #122 · Documentation › Doc review · 24 Apr 2025 · 3 likes Coming back to post #120, because the follow-up matters more than the original answer. Citation checking: if a maintained page cites a paper, the citation should match…
-
Requesting a page: what makes a good request Replied, post #62 · Documentation › Wiki requests · 18 Apr 2025 · 1 like Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #28 · Evidence › Journal club · 18 Apr 2025 · 7 likes Coming back to post #26, because the follow-up matters more than the original answer. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Started this topic · Compounds › Retatrutide · 26 Mar 2025 · 5 likes On the subject in the title: Retatrutide phase 2 in type 2 diabetes: the Lancet paper Working notes rather than a conclusion. I have seen STEP 2 ( Lancet , 2021) cited…
-
Adjudicated events and why the definition matters — the long version Replied, post #59 · Evidence › Trials · 22 Mar 2025 · 0 likes post #58 answers the question as asked. The question underneath it is different. The estimand: what the trial set out to estimate. Two trials can be identical in…
-
About the Red flags category Replied, post #4 · Sourcing › Red flags · 3 Mar 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #38 · Analytics › COA interpretation · 1 Mar 2025 · 5 likes post #37 is right about the mechanism and I think understates the practical bit. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #107 · Evidence › Meta-analyses · 13 Feb 2025 · 27 likes Worth separating two things that post #103 runs together. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g.,…
-
Reading a supplementary appendix and finding the interesting part Replied, post #89 · Evidence › Trials · 10 Feb 2025 · 0 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class Started this topic · Clinical › Comorbidities · 9 Feb 2025 · 4 likes Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Asking about a…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #41 · Evidence › Meta-analyses · 2 Feb 2025 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Fixed versus detachable needles: the trade-offs Replied, post #106 · Devices › Syringes & needles · 11 Jan 2025 · 20 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Recovery when intake is low: what to cut first Replied, post #36 · Nutrition & Training › Resistance training · 11 Jan 2025 · 7 likes I read post #34 twice before replying, because I had assumed the opposite. Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of…
-
Coming back to: When to suspect the method rather than the sample Replied, post #134 · Analytics › Method validation · 25 Dec 2024 · 3 likes Picking up post #131: that is the part I would want checked first. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #29 · Compounds › Secretagogues & GH axis · 16 Dec 2024 · 3 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Coming back to: An 18-month record including the parts that went badly Started this topic · Outcomes › Progress reports · 15 Dec 2024 · 4 likes Posting this under the heading it deserves: An 18-month record including the parts that went badly Everything below is what sits behind that. Longitudinal report with…
-
Promotion criteria, and the one that stops most nominations Replied, post #139 · Documentation › Doc review · 13 Dec 2024 · 19 likes I read post #137 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #62 · Clinical › Special populations · 24 Nov 2024 · 29 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #7 · Access › Shortages · 8 Oct 2024 · 20 likes I read post #5 twice before replying, because I had assumed the opposite. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Revisiting: Five questions in one post gets you one answer — how to split them Replied, post #4 · marked as the solution · Start Here › How to Ask · 5 Oct 2024 · 9 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #2 · Sourcing › Red flags · 28 Sep 2024 · 5 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #16 · Compounds › Retatrutide · 3 Sep 2024 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Circumference measurements as a poor man's composition estimate Replied, post #102 · Outcomes › Body composition · 27 Aug 2024 · 22 likes post #101 answers the question as asked. The question underneath it is different. Bioelectric impedance analysis: less precise than DXA and strongly affected by…
-
Circumference measurements as a poor man's composition estimate Replied, post #89 · Outcomes › Body composition · 22 Aug 2024 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Reporting a discrepancy without making an allegation Replied, post #34 · Sourcing › Vendor reports · 19 Aug 2024 · 6 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…